GLASF vs OHCFF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and OHCFF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GLASF’s FA Score shows that 0 FA rating(s) are green while.
- GLASF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GLASF’s TA Score shows that 4 TA indicator(s) are bullish.
- GLASF’s TA Score: 4 bullish, 6 bearish.
Price Growth
GLASF (@Pharmaceuticals: Other) experienced а -9.80% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.06%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +15.65%.
Industries' Descriptions
@Pharmaceuticals: Other (-0.06% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| GLASF | OHCFF | GLASF / OHCFF | |
| Capitalization | 204M | 464K | 43,966% |
| EBITDA | -24.02M | -181.76K | 13,215% |
| Gain YTD | 6.379 | 25.017 | 26% |
| P/E Ratio | N/A | 3.23 | - |
| Revenue | 106M | 0 | - |
| Total Cash | 13.4M | 810K | 1,654% |
| Total Debt | 73.6M | 40K | 184,000% |
GLASF | OHCFF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 93 | 95 | |
PRICE GROWTH RATING 1..100 | 39 | 46 | |
P/E GROWTH RATING 1..100 | 100 | 66 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OHCFF's Valuation (41) in the null industry is somewhat better than the same rating for GLASF (97). This means that OHCFF’s stock grew somewhat faster than GLASF’s over the last 12 months.
OHCFF's Profit vs Risk Rating (100) in the null industry is in the same range as GLASF (100). This means that OHCFF’s stock grew similarly to GLASF’s over the last 12 months.
GLASF's SMR Rating (93) in the null industry is in the same range as OHCFF (95). This means that GLASF’s stock grew similarly to OHCFF’s over the last 12 months.
GLASF's Price Growth Rating (39) in the null industry is in the same range as OHCFF (46). This means that GLASF’s stock grew similarly to OHCFF’s over the last 12 months.
OHCFF's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for GLASF (100). This means that OHCFF’s stock grew somewhat faster than GLASF’s over the last 12 months.
| GLASF | |
|---|---|
| RSI ODDS (%) | 2 days ago 69% |
| Stochastic ODDS (%) | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 73% |
| MACD ODDS (%) | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 66% |
| Advances ODDS (%) | 11 days ago 77% |
| Declines ODDS (%) | 4 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 72% |
GLASF and
Correlation & Price change
A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.
| Ticker / NAME | Correlation To GLASF | 1D Price Change % | ||
|---|---|---|---|---|
| GLASF | 100% | -1.44% | ||
| TSNDF - GLASF | 63% Loosely correlated | +0.07% | ||
| GTBIF - GLASF | 62% Loosely correlated | -4.97% | ||
| TCNNF - GLASF | 60% Loosely correlated | -2.42% | ||
| VRNOF - GLASF | 58% Loosely correlated | -6.76% | ||
| CURLF - GLASF | 57% Loosely correlated | -5.87% | ||
More | ||||
OHCFF and
Correlation & Price change
A.I.dvisor tells us that OHCFF and SWDCF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OHCFF and SWDCF's prices will move in lockstep.
| Ticker / NAME | Correlation To OHCFF | 1D Price Change % | ||
|---|---|---|---|---|
| OHCFF | 100% | -6.24% | ||
| SWDCF - OHCFF | 22% Poorly correlated | N/A | ||
| HYEX - OHCFF | 10% Poorly correlated | N/A | ||
| TKNO - OHCFF | 7% Poorly correlated | +9.26% | ||
| GLASF - OHCFF | 1% Poorly correlated | -1.44% | ||
| UPC - OHCFF | 1% Poorly correlated | +2.09% | ||
More | ||||